We advised Privia on its SEC-registered offering of stock

Davis Polk advised Privia Health Group, Inc. in connection with an SEC-registered secondary offering of 6,000,000 shares of common stock by certain selling stockholders for approximately $174 million in total gross proceeds. The shares of common stock are listed on the Nasdaq Global Select Market under the symbol “PRVA.”

Privia Health is a technology-driven, national physician enablement company that collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health’s platform is led by top industry talent and exceptional physician leadership, and consists of scalable operations and end-to-end, cloud-based technology that reduces unnecessary healthcare costs, achieves better outcomes and improves the health of patients and the well-being of providers.

The Davis Polk capital markets team included partner Richard D. Truesdell Jr. and associates Chris Van Buren and Michael Jiang. The executive compensation team included partner Kyoko Takahashi Lin, counsel Stephen I. Brecher and associate Melissa Esposito. The intellectual property and technology transactions team included partner Pritesh P. Shah and associate Jesse L. Hallock. The tax team included associates Daniel L. Jose and Dylan J. Steiner. All members of the Davis Polk team are based in the New York office.